Samsung Pharmaceutical Co (XKRX:001360) Interest Expense : ₩-231 Mil (TTM As of Dec. 2024)

View and export this data going back to 1975. Start your Free Trial

What is Samsung Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Samsung Pharmaceutical Co's interest expense for the three months ended in Dec. 2024 was ₩ -66 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-231 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Samsung Pharmaceutical Co's Operating Income for the three months ended in Dec. 2024 was ₩ -2,886 Mil. Samsung Pharmaceutical Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -66 Mil. Samsung Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Samsung Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Samsung Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung Pharmaceutical Co Interest Expense Chart

Samsung Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-2,085.89

-506.88

-111.09

-73.37

-231.04

Samsung Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-13.41	-39.08	-52.96	-73.27	-65.73

Samsung Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-231 Mil.

Samsung Pharmaceutical Co (XKRX:001360) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Samsung Pharmaceutical Co's Interest Expense for the three months ended in Dec. 2024 was ₩-66 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-2,886 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩362 Mil.

Samsung Pharmaceutical Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Samsung Pharmaceutical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Samsung Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samsung Pharmaceutical Co Ltd (XKRX:001360) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

35 Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong, KOR, 445-746

Website

http://www.sspharm.co.kr

Samsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacturing, supply, and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides, and healthcare food items.

Samsung Pharmaceutical Co Headlines

No Headlines